HEADER HYDROLASE 17-AUG-13 4C2F TITLE CRYSTAL STRUCTURE OF THE CTPB R168A MUTANT PRESENT IN AN ACTIVE TITLE 2 CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXY-TERMINAL PROCESSING PROTEASE CTPB; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 44-480; COMPND 5 SYNONYM: C-TERMINAL PROCESSING PROTEASE, CTPB; COMPND 6 EC: 3.4.21.102; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE1; COMPND 11 CHAIN: B; COMPND 12 OTHER_DETAILS: PEPTIDE CO-PURIFIED FROM E. COLI EXPRESSION; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: PEPTIDE2; COMPND 15 CHAIN: C; COMPND 16 OTHER_DETAILS: PEPTIDE CO-PURIFIED FROM E. COLI EXPRESSION SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS SUBSP. SUBTILIS STR. 168; SOURCE 3 ORGANISM_TAXID: 224308; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET21; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 10 ORGANISM_TAXID: 511693; SOURCE 11 STRAIN: BL21; SOURCE 12 MOL_ID: 3; SOURCE 13 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 14 ORGANISM_TAXID: 511693; SOURCE 15 STRAIN: BL21 KEYWDS HYDROLASE, PROTEOLYTIC TUNNEL EXPDTA X-RAY DIFFRACTION AUTHOR M.MASTNY,A.HEUCK,R.KURZBAUER,T.CLAUSEN REVDAT 2 20-DEC-23 4C2F 1 LINK REVDAT 1 04-DEC-13 4C2F 0 JRNL AUTH M.MASTNY,A.HEUCK,R.KURZBAUER,A.HEIDUK,P.BOISGUERIN, JRNL AUTH 2 R.VOLKMER,M.EHRMANN,C.D.A.RODRIGUES,D.Z.RUDNER,T.CLAUSEN JRNL TITL CTPB ASSEMBLES A GATED PROTEASE TUNNEL REGULATING CELL-CELL JRNL TITL 2 SIGNALING DURING SPORE FORMATION IN BACILLUS SUBTILIS. JRNL REF CELL(CAMBRIDGE,MASS.) V. 155 647 2013 JRNL REFN ISSN 0092-8674 JRNL PMID 24243021 JRNL DOI 10.1016/J.CELL.2013.09.050 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 22041 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1121 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3429 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.23400 REMARK 3 B22 (A**2) : 7.23400 REMARK 3 B33 (A**2) : -14.46800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 86.04 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C2F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1290058063. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22841 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 19.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -10.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.01000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 44.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C2C REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1 M NA-MALONATE PH 7.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.03200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.01600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 24.01600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 48.03200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 43 REMARK 465 ALA A 44 REMARK 465 ASP A 45 REMARK 465 ASN A 480 REMARK 465 LEU A 481 REMARK 465 GLU A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 465 HIS A 488 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 479 CA C O CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 67 0.23 -48.03 REMARK 500 ALA A 116 144.85 -174.20 REMARK 500 PRO A 143 152.28 -48.48 REMARK 500 ILE A 148 -61.10 -94.08 REMARK 500 ALA A 156 87.82 -56.85 REMARK 500 PRO A 182 47.34 -70.53 REMARK 500 LYS A 265 6.10 -57.55 REMARK 500 LYS A 270 2.20 -56.65 REMARK 500 GLU A 279 -166.99 -115.26 REMARK 500 LYS A 285 99.96 179.34 REMARK 500 SER A 309 -116.84 52.26 REMARK 500 ASP A 345 29.52 -178.22 REMARK 500 LYS A 367 -47.16 -132.43 REMARK 500 GLU A 418 26.60 -140.50 REMARK 500 SER A 462 39.47 -71.87 REMARK 500 LEU A 477 4.03 -68.79 REMARK 500 PHE A 478 -52.55 -140.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROTEASE CTPB IN AN ACTIVE STATE REMARK 900 RELATED ID: 4C2D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROTEASE CTPB IN AN ACTIVE STATE REMARK 900 RELATED ID: 4C2E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROTEASE CTPB(S309A) PRESENT IN A RESTING REMARK 900 STATE REMARK 900 RELATED ID: 4C2G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTPB(S309A) IN COMPLEX WITH A PEPTIDE HAVING A REMARK 900 VAL-PRO-ALA C-TERMINUS REMARK 900 RELATED ID: 4C2H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CTPB(V118Y) MUTANT DBREF 4C2F A 44 480 UNP O35002 CTPB_BACSU 44 480 DBREF 4C2F B 3 5 PDB 4C2F 4C2F 3 5 DBREF 4C2F C 1 7 PDB 4C2F 4C2F 1 7 SEQADV 4C2F MSE A 43 UNP O35002 INITIATING METHIONINE SEQADV 4C2F LEU A 481 UNP O35002 EXPRESSION TAG SEQADV 4C2F GLU A 482 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 483 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 484 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 485 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 486 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 487 UNP O35002 EXPRESSION TAG SEQADV 4C2F HIS A 488 UNP O35002 EXPRESSION TAG SEQADV 4C2F ALA A 168 UNP O35002 ARG 168 ENGINEERED MUTATION SEQRES 1 A 446 MSE ALA ASP SER GLU ARG ASP LYS ALA MSE ASP LYS ILE SEQRES 2 A 446 GLU LYS ALA TYR GLU LEU ILE SER ASN GLU TYR VAL GLU SEQRES 3 A 446 LYS VAL ASP ARG GLU LYS LEU LEU GLU GLY ALA ILE GLN SEQRES 4 A 446 GLY MSE LEU SER THR LEU ASN ASP PRO TYR SER VAL TYR SEQRES 5 A 446 MSE ASP LYS GLN THR ALA LYS GLN PHE SER ASP SER LEU SEQRES 6 A 446 ASP SER SER PHE GLU GLY ILE GLY ALA GLU VAL GLY MSE SEQRES 7 A 446 GLU ASP GLY LYS ILE ILE ILE VAL SER PRO PHE LYS LYS SEQRES 8 A 446 SER PRO ALA GLU LYS ALA GLY LEU LYS PRO ASN ASP GLU SEQRES 9 A 446 ILE ILE SER ILE ASN GLY GLU SER MSE ALA GLY LYS ASP SEQRES 10 A 446 LEU ASN HIS ALA VAL LEU LYS ILE ALA GLY LYS LYS GLY SEQRES 11 A 446 SER SER VAL SER MSE LYS ILE GLN ARG PRO GLY THR LYS SEQRES 12 A 446 LYS GLN LEU SER PHE ARG ILE LYS ARG ALA GLU ILE PRO SEQRES 13 A 446 LEU GLU THR VAL PHE ALA SER GLU LYS LYS VAL GLN GLY SEQRES 14 A 446 HIS SER VAL GLY TYR ILE ALA ILE SER THR PHE SER GLU SEQRES 15 A 446 HIS THR ALA GLU ASP PHE ALA LYS ALA LEU ARG GLU LEU SEQRES 16 A 446 GLU LYS LYS GLU ILE GLU GLY LEU VAL ILE ASP VAL ARG SEQRES 17 A 446 GLY ASN PRO GLY GLY TYR LEU GLN SER VAL GLU GLU ILE SEQRES 18 A 446 LEU LYS HIS PHE VAL THR LYS ASP GLN PRO TYR ILE GLN SEQRES 19 A 446 ILE ALA GLU ARG ASN GLY ASP LYS LYS ARG TYR PHE SER SEQRES 20 A 446 THR LEU THR HIS LYS LYS ALA TYR PRO VAL ASN VAL ILE SEQRES 21 A 446 THR ASP LYS GLY SER ALA SER ALA SER GLU ILE LEU ALA SEQRES 22 A 446 GLY ALA LEU LYS GLU ALA GLY HIS TYR ASP VAL VAL GLY SEQRES 23 A 446 ASP THR SER PHE GLY LYS GLY THR VAL GLN GLN ALA VAL SEQRES 24 A 446 PRO MSE GLY ASP GLY SER ASN ILE LYS LEU THR LEU TYR SEQRES 25 A 446 LYS TRP LEU THR PRO ASN GLY ASN TRP ILE HIS LYS LYS SEQRES 26 A 446 GLY ILE GLU PRO THR ILE ALA ILE LYS GLN PRO ASP TYR SEQRES 27 A 446 PHE SER ALA GLY PRO LEU GLN LEU LYS GLU PRO LEU LYS SEQRES 28 A 446 VAL ASP MSE ASN ASN GLU ASP VAL LYS HIS ALA GLN VAL SEQRES 29 A 446 LEU LEU LYS GLY LEU SER PHE ASP PRO GLY ARG GLU ASP SEQRES 30 A 446 GLY TYR PHE SER LYS ASP MSE LYS LYS ALA VAL MSE ALA SEQRES 31 A 446 PHE GLN ASP GLN ASN LYS LEU ASN LYS THR GLY VAL ILE SEQRES 32 A 446 ASP THR ARG THR ALA GLU THR LEU ASN GLN GLN ILE GLU SEQRES 33 A 446 LYS LYS LYS SER ASP GLU LYS ASN ASP LEU GLN LEU GLN SEQRES 34 A 446 THR ALA LEU LYS SER LEU PHE VAL ASN LEU GLU HIS HIS SEQRES 35 A 446 HIS HIS HIS HIS SEQRES 1 B 3 ALA ALA ALA SEQRES 1 C 7 ALA ALA ALA ALA SER ALA ALA MODRES 4C2F MSE A 52 MET SELENOMETHIONINE MODRES 4C2F MSE A 83 MET SELENOMETHIONINE MODRES 4C2F MSE A 95 MET SELENOMETHIONINE MODRES 4C2F MSE A 120 MET SELENOMETHIONINE MODRES 4C2F MSE A 155 MET SELENOMETHIONINE MODRES 4C2F MSE A 177 MET SELENOMETHIONINE MODRES 4C2F MSE A 343 MET SELENOMETHIONINE MODRES 4C2F MSE A 396 MET SELENOMETHIONINE MODRES 4C2F MSE A 426 MET SELENOMETHIONINE MODRES 4C2F MSE A 431 MET SELENOMETHIONINE HET MSE A 52 8 HET MSE A 83 8 HET MSE A 95 8 HET MSE A 120 8 HET MSE A 155 8 HET MSE A 177 8 HET MSE A 343 8 HET MSE A 396 8 HET MSE A 426 8 HET MSE A 431 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 4 HOH *70(H2 O) HELIX 1 1 SER A 46 TYR A 66 1 21 HELIX 2 2 ASP A 71 THR A 86 1 16 HELIX 3 3 ASP A 96 LEU A 107 1 12 HELIX 4 4 SER A 134 ALA A 139 1 6 HELIX 5 5 ASP A 159 LEU A 165 1 7 HELIX 6 6 HIS A 225 LYS A 239 1 15 HELIX 7 7 TYR A 256 LYS A 265 1 10 HELIX 8 8 SER A 309 ALA A 321 1 13 HELIX 9 9 ASP A 379 GLY A 384 1 6 HELIX 10 10 ASN A 398 LEU A 411 1 14 HELIX 11 11 SER A 423 ASN A 437 1 15 HELIX 12 12 ASP A 446 SER A 462 1 17 HELIX 13 13 ASP A 463 ASN A 466 5 4 HELIX 14 14 ASP A 467 LEU A 477 1 11 SHEET 1 AA 2 VAL A 93 MSE A 95 0 SHEET 2 AA 2 ASN A 348 LEU A 357 -1 O ASN A 348 N MSE A 95 SHEET 1 AB 5 ARG A 286 TYR A 287 0 SHEET 2 AB 5 ILE A 275 ALA A 278 -1 O ILE A 275 N TYR A 287 SHEET 3 AB 5 ASN A 348 LEU A 357 -1 O LYS A 355 N ALA A 278 SHEET 4 AB 5 THR A 336 PRO A 342 -1 O VAL A 337 N LEU A 353 SHEET 5 AB 5 ALA B 4 ALA B 5 -1 O ALA B 5 N GLN A 338 SHEET 1 AC 4 ARG A 286 TYR A 287 0 SHEET 2 AC 4 ILE A 275 ALA A 278 -1 O ILE A 275 N TYR A 287 SHEET 3 AC 4 ASN A 348 LEU A 357 -1 O LYS A 355 N ALA A 278 SHEET 4 AC 4 VAL A 93 MSE A 95 -1 O VAL A 93 N LYS A 350 SHEET 1 AD 2 SER A 110 GLY A 113 0 SHEET 2 AD 2 ALA A 195 PRO A 198 -1 O ALA A 195 N GLY A 113 SHEET 1 AE 2 ALA A 116 GLU A 121 0 SHEET 2 AE 2 LYS A 124 PRO A 130 -1 O LYS A 124 N GLU A 121 SHEET 1 AF 4 GLU A 153 SER A 154 0 SHEET 2 AF 4 GLU A 146 ILE A 150 -1 O ILE A 150 N GLU A 153 SHEET 3 AF 4 SER A 174 GLN A 180 -1 O LYS A 178 N ILE A 148 SHEET 4 AF 4 GLN A 187 LYS A 193 -1 O LEU A 188 N ILE A 179 SHEET 1 AG 6 VAL A 202 VAL A 209 0 SHEET 2 AG 6 HIS A 212 ILE A 219 -1 O HIS A 212 N VAL A 209 SHEET 3 AG 6 LEU A 245 ASP A 248 1 O VAL A 246 N ILE A 217 SHEET 4 AG 6 VAL A 299 THR A 303 1 O ASN A 300 N ILE A 247 SHEET 5 AG 6 ASP A 325 GLY A 328 1 O ASP A 325 N VAL A 301 SHEET 6 AG 6 ILE A 373 ALA A 374 1 O ILE A 373 N GLY A 328 LINK C ALA A 51 N MSE A 52 1555 1555 1.33 LINK C MSE A 52 N ASP A 53 1555 1555 1.33 LINK C GLY A 82 N MSE A 83 1555 1555 1.33 LINK C MSE A 83 N LEU A 84 1555 1555 1.33 LINK C TYR A 94 N MSE A 95 1555 1555 1.33 LINK C MSE A 95 N ASP A 96 1555 1555 1.33 LINK C GLY A 119 N MSE A 120 1555 1555 1.33 LINK C MSE A 120 N GLU A 121 1555 1555 1.33 LINK C SER A 154 N MSE A 155 1555 1555 1.34 LINK C MSE A 155 N ALA A 156 1555 1555 1.33 LINK C SER A 176 N MSE A 177 1555 1555 1.33 LINK C MSE A 177 N LYS A 178 1555 1555 1.33 LINK C PRO A 342 N MSE A 343 1555 1555 1.33 LINK C MSE A 343 N GLY A 344 1555 1555 1.33 LINK C ASP A 395 N MSE A 396 1555 1555 1.33 LINK C MSE A 396 N ASN A 397 1555 1555 1.33 LINK C ASP A 425 N MSE A 426 1555 1555 1.32 LINK C MSE A 426 N LYS A 427 1555 1555 1.33 LINK C VAL A 430 N MSE A 431 1555 1555 1.33 LINK C MSE A 431 N ALA A 432 1555 1555 1.33 CRYST1 117.909 117.909 72.048 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008481 0.004897 0.000000 0.00000 SCALE2 0.000000 0.009793 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013880 0.00000